Binkley Neil C, Schmeer Peg, Wasnich Richard D, Lenchik Leon
J Clin Densitom. 2002;5 Suppl:S19-27. doi: 10.1385/jcd:5:3s:s19.
Osteoporotic fractures are not rare in men or non-Caucasian women. However, for these groups, there is no consensus densitometric definition of osteoporosis. As is the case in Caucasian women, low bone mineral density (BMD) is associated with increased fracture risk among men and non-Caucasian women; thus, a densitometric definition of osteoporosis seems feasible. Reaching agreement on criteria for diagnosing osteoporosis in men and non-Caucasians was among the goals of the International Society for Clinical Densitometry Position Development Conference held in July 2001. To this end, the conference recommendation for males is that osteoporosis be defined as a BMD T-score of -2.5 or below the young normal mean for men. Since the relationship between BMD and fracture risk may differ between men and women, it is recommended that T scores in men continue to be derived using a male normative database. Similarly, for non-Caucasians, the recommendation is to diagnose osteoporosis at or below a T-score of -2.5. However, given the difficulty in defining race or ethnic groups, a dearth of data, and their conflicting nature correlating BMD with fracture risk in different ethnicities, it is recommended that a uniform normative database (not adjusted for race) be utilized in the United States for T-score derivation in non-Caucasians. Note that these are current clinical recommendations, which may change as additional data accumulate. Furthermore, there was agreement that the following individuals should have their bone density measured: anyone (male or female, regardless of race) with prior fragility fractures or with conditions widely recognized to increase the risk of bone loss and fracture (such as hypogonadism, corticosteroid treatment, hyperparathyroidism, alcohol abuse, anticonvulsant use, and prior gastrectomy); women on long-term hormone replacement therapy; and in the absence of these conditions, women age 65 and older (regardless of race) and men age 70 and older.
骨质疏松性骨折在男性或非白种女性中并不罕见。然而,对于这些群体,骨质疏松症的骨密度定义尚无共识。与白种女性的情况一样,低骨密度(BMD)与男性和非白种女性骨折风险增加相关;因此,骨质疏松症的骨密度定义似乎是可行的。就男性和非白种人骨质疏松症的诊断标准达成一致是2001年7月举行的国际临床骨密度测量学会立场发展会议的目标之一。为此,该会议对男性的建议是,骨质疏松症定义为骨密度T值低于男性年轻正常平均值-2.5或更低。由于男性和女性之间骨密度与骨折风险的关系可能不同,建议继续使用男性标准数据库得出男性的T值。同样,对于非白种人,建议在T值为-2.5或更低时诊断为骨质疏松症。然而,鉴于难以界定种族或族裔群体、数据匮乏以及不同种族中骨密度与骨折风险相关性的矛盾性质,建议在美国使用统一的标准数据库(不根据种族调整)来得出非白种人的T值。请注意,这些是当前的临床建议,可能会随着更多数据的积累而改变。此外,会议还达成共识,以下人群应进行骨密度测量:任何有既往脆性骨折或患有广泛认可的增加骨质流失和骨折风险疾病(如性腺功能减退、皮质类固醇治疗、甲状旁腺功能亢进、酗酒、使用抗惊厥药物以及既往胃切除术)的人(男性或女性,无论种族);接受长期激素替代治疗的女性;以及在没有这些情况时,65岁及以上的女性(无论种族)和70岁及以上的男性。